NO20075650L - Tri- eller tetrasubstituterte 3-aminopyrrolidinderivater - Google Patents

Tri- eller tetrasubstituterte 3-aminopyrrolidinderivater

Info

Publication number
NO20075650L
NO20075650L NO20075650A NO20075650A NO20075650L NO 20075650 L NO20075650 L NO 20075650L NO 20075650 A NO20075650 A NO 20075650A NO 20075650 A NO20075650 A NO 20075650A NO 20075650 L NO20075650 L NO 20075650L
Authority
NO
Norway
Prior art keywords
hydrogen atom
carbon atoms
alkyl group
group containing
represent
Prior art date
Application number
NO20075650A
Other languages
English (en)
Inventor
Hisashi Takahashi
Rie Miyauchi
Makoto Takemura
Hiroaki Inagaki
Satoshi Komoriya
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37431361&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20075650(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of NO20075650L publication Critical patent/NO20075650L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Det er tilveiebrakt et syntetisk, antibakterielt kinolon-middel og et terapeutisk middel mot en infeksjon, som har bredspektret og sterk antibakteriell virkning mot både gram-positive og gram-negative bakterier, og som er også er meget sikkert. Forbindelsen som er tilveiebrakt, er representert ved følgende formel (I): hvor R1 og R2 representerer et hydrogenatom eller lignende; R3 representerer en alkylgruppe som inneholder 1 til 6 karbonatomer, eller lignende; R4 og R5 representerer uavhengig av hverandre et hydrogenatom, en alkylgruppe som inneholder 1 til 6 karbonatomer, eller lignende, med det forbehold at R4 og R5 ikke samtidig representerer et hydrogenatom; eller substituentene R4 og R5 sammen representerer (a) en 3- til 6-leddet, cyklisk struktur som omfatter karbonatomet som er felles for R4 og R5, og danner en spirocyklisk struktur med pyrrolidinringen; R6 og R7 representerer uavhengig av hverandre et hydrogenatom, en alkylgruppe som inneholder 1 til 6 karbonatomer, eller lignende; R8 representerer en halogen-substituert alkylgruppe som inneholder 1 til 6 karbonatomer, eller lignende; X1 representerer et hydrogenatom eller et halogenatom; A representerer et nitrogenatom eller en gruppe som er representert ved formel (II):
NO20075650A 2005-05-19 2007-11-06 Tri- eller tetrasubstituterte 3-aminopyrrolidinderivater NO20075650L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2005146386 2005-05-19
JP2005344514 2005-11-29
JP2006080629 2006-03-23
PCT/JP2006/310069 WO2006123792A1 (ja) 2005-05-19 2006-05-19 トリ－、テトラ－置換－３－アミノピロリジン誘導体

Publications (1)

Publication Number Publication Date
NO20075650L true NO20075650L (no) 2007-12-13

Family

ID=37431361

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075650A NO20075650L (no) 2005-05-19 2007-11-06 Tri- eller tetrasubstituterte 3-aminopyrrolidinderivater

Country Status (15)

Country Link
US (3) US7563805B2 (no)
EP (2) EP2463274A1 (no)
JP (2) JP5087394B2 (no)
KR (1) KR101307717B1 (no)
AR (1) AR054272A1 (no)
AU (1) AU2006248354B2 (no)
BR (1) BRPI0610114A2 (no)
CA (1) CA2608468C (no)
ES (1) ES2422858T3 (no)
IL (1) IL186815A (no)
MY (1) MY143605A (no)
NO (1) NO20075650L (no)
NZ (1) NZ562959A (no)
TW (1) TWI384987B (no)
WO (1) WO2006123792A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1757598A4 (en) * 2004-05-13 2010-07-21 Daiichi Seiyaku Co SUBSTITUTED PYRROLIDINE DERIVATIVE
TW200640899A (en) * 2005-01-21 2006-12-01 Daiichi Seiyaku Co Fluoroalkylpyrrolidine derivative
US7563805B2 (en) 2005-05-19 2009-07-21 Daiichi Pharmaceutical Co., Ltd. Tri-, tetra-substituted-3-aminopyrrolidine derivative
US7928232B2 (en) * 2005-05-20 2011-04-19 Daiichi Sankyo Company, Limited Method for producing asymmetric tetrasubstituted carbon atom-containing compound
JP5073497B2 (ja) * 2005-09-28 2012-11-14 第一三共株式会社 テトラ置換−５−アザスピロ［２．４］へプタン誘導体の製法およびその光学活性中間体
US8129533B2 (en) * 2005-09-28 2012-03-06 Dalichi Sankyo Company, Limited Method for production of quinolone-containing lyophilized preparation
US7977346B2 (en) 2006-01-17 2011-07-12 Guoqing Paul Chen Spiro compounds and methods of use
TWI386401B (zh) * 2006-03-27 2013-02-21 Daiichi Seiyaku Co 醫藥用水合物
MX2009007291A (es) * 2007-01-05 2009-07-14 Daiichi Sankyo Co Ltd Derivado de aminopirrolidina sustituido fusionado.
JP5174365B2 (ja) * 2007-03-23 2013-04-03 第一三共株式会社 キノロン含有凍結乾燥製剤の製造方法
EP2195319A4 (en) 2007-09-21 2011-09-14 Epiphany Biosciences Inc POLYMORPHS OF VALOMACICLOVIR
US9359303B2 (en) 2009-04-21 2016-06-07 Purdue Research Foundation Octahydrobenzoisoquinoline modulators of dopamine receptors and uses therefor
EP2709455A4 (en) 2011-05-18 2014-11-05 Enanta Pharm Inc PROCESSES FOR THE PREPARATION OF 5-AZASPIRO [2.4] HEPTANE-6-CARBOXYLIC ACID AND ITS DERIVATIVES
WO2014115648A1 (ja) 2013-01-25 2014-07-31 株式会社アイエイアイ アクチュエータ
WO2019025250A1 (en) 2017-08-04 2019-02-07 Basf Se SUBSTITUTED TRIFLUOROMETHYLOXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI
CN113395131A (zh) 2020-03-12 2021-09-14 华为技术有限公司 数据传输方法及相关装置

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5872589A (ja) 1981-10-28 1983-04-30 Dai Ichi Seiyaku Co Ltd ピリド〔１，２，３−ｄｅ〕〔１，４〕ベンゾオキサジン誘導体
US4822801A (en) * 1984-07-20 1989-04-18 Warner-Lambert Company 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents
IE58742B1 (en) 1984-07-20 1993-11-05 Warner Lambert Co Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds
JPS61137885A (ja) 1984-12-08 1986-06-25 Dainippon Pharmaceut Co Ltd １，８−ナフチリジン誘導体、そのエステルおよびその塩
JPS61152682A (ja) 1984-12-27 1986-07-11 Dainippon Pharmaceut Co Ltd ピリドンカルボン酸誘導体、そのエステルおよびその塩
JPS61282382A (ja) 1985-06-06 1986-12-12 Dainippon Pharmaceut Co Ltd フエニル置換１，８−ナフチリジン誘導体、そのエステルおよびその塩
JPH0635457B2 (ja) * 1985-06-28 1994-05-11 杏林製薬株式会社 ピリドンカルボン酸誘導体およびその製造方法
US4735949A (en) * 1986-02-18 1988-04-05 Warner-Lambert Company Disubstituted-7-pyrrolidinonaphthyridine antibacterial agents
JPS63198664A (ja) * 1986-03-31 1988-08-17 Sankyo Co Ltd キノロンカルボン酸誘導体
EP0242789A3 (en) * 1986-04-25 1990-09-05 Dainippon Pharmaceutical Co., Ltd. Novel quinoline derivates and processes for preparation thereof
JPS63152318A (ja) 1986-08-07 1988-06-24 Dainippon Pharmaceut Co Ltd 抗マイコプラズマ剤
ZW16387A1 (en) * 1986-09-12 1988-05-25 Hoffmann La Roche Tricyclic compounds
ES2059335T3 (es) 1986-09-12 1994-11-16 Hoffmann La Roche Derivados de pirido(3,2,1-ij)-1,3,4-benzoxadiazina, procedimiento para su obtencion, preparados farmaceuticos correspondientes y productos intermedios utilizables en el procedimiento.
NZ222047A (en) 1986-10-08 1991-01-29 Bristol Myers Co Quinoline - or naphthyridine - carboxylic acid anti-bacterial agents
JPS63130594A (ja) 1986-11-21 1988-06-02 Tokyo Tanabe Co Ltd ベンゾ〔ｉｊ〕キノリジン−２−カルボン酸化合物及びその製造法
JPS63188626A (ja) 1987-01-30 1988-08-04 Dainippon Pharmaceut Co Ltd ピリドンカルボン酸の可溶化方法
MY105136A (en) 1988-04-27 1994-08-30 Daiichi Seiyaku Co Optically active pyridonecarboxylic acid derivatives.
US5286723A (en) * 1988-08-31 1994-02-15 Daiichi Seiyaku Co., Ltd. Spiro compound
JP2807277B2 (ja) 1988-08-31 1998-10-08 第一製薬株式会社 スピロ化合物
CA1336090C (en) 1988-08-31 1995-06-27 Isao Hayakawa Spiro-substituted cyclic amines of quinolone derivatives
US5324735A (en) * 1989-07-21 1994-06-28 Ss Pharmaceutical Co., Ltd. Quinoline carboxylic acid derivatives
JP2991381B2 (ja) 1990-07-16 1999-12-20 大日本製薬株式会社 新規キノリンカルボン酸誘導体、そのエステルおよびその塩
KR920004385A (ko) 1990-08-09 1992-03-27 와꾸나가 기스께 신규 삼환화합물 또는 그의 염, 이의 제조방법 및 이를 함유하는 항균제
JPH0559052A (ja) * 1990-08-09 1993-03-09 Wakunaga Pharmaceut Co Ltd 新規三環性化合物又はその塩及びこれを含有する抗菌剤
US5696132A (en) * 1991-05-28 1997-12-09 Daiichi Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivatives
DE4123918A1 (de) 1991-07-19 1993-01-21 Bayer Ag 8-vinyl- und 8-ethinyl-chinoloncarbonsaeuren
US5468742A (en) 1991-07-19 1995-11-21 Bayer Aktiengesellschaft 8-vinyl- and 9-ethinyl-quinolone-carboxylic acids
KR930703292A (ko) 1991-12-27 1993-11-29 쿠사이 요시히로 신규 퀴놀론 유도체 또는 그의 염 및 이 화합물을 함유하는 항균제
JPH05279364A (ja) 1992-02-07 1993-10-26 Wakunaga Pharmaceut Co Ltd 新規三環性化合物又はその塩及びこれを含有する抗菌剤
WO1993025545A1 (en) * 1992-06-09 1993-12-23 Korea Research Institute Of Chemical Technology Novel quinoline derivatives and processes for preparing the same
JPH06228138A (ja) 1993-02-03 1994-08-16 Fujisawa Pharmaceut Co Ltd ピリドシンノリン化合物またはその塩及びこれを含有する抗菌剤
TW273551B (no) * 1993-05-24 1996-04-01 Wakiei Seiyaku Kk
JPH0725873A (ja) 1993-07-09 1995-01-27 Wakunaga Pharmaceut Co Ltd キノロン誘導体又はその塩並びに該化合物を含有する抗菌剤
PL181867B1 (pl) 1994-06-14 2001-09-28 Dainippon Pharmaceutical Co Nowe zwiazki, sposoby ich wytwarzania i srodki przeciw nowotworowe PL
DE69531305T2 (de) * 1994-10-20 2004-05-13 Wakunaga Seiyaku K.K. Pyridoncarboxylat- derivate oder salze davon und antibakterielle zusammensetzungen die diese als aktiven bestandteil enthalten
KR100499366B1 (ko) 1995-01-30 2005-09-08 와쿠나가 세이야쿠 가부시키 가이샤 신규피리돈카르복실산유도체또는그염및그물질을유효성분으로하는항균제
JP4323574B2 (ja) 1995-12-13 2009-09-02 大日本住友製薬株式会社 抗腫瘍剤
CN1268132A (zh) * 1997-06-24 2000-09-27 第一制药株式会社 顺式－取代的氟甲基吡咯烷衍生物
AU2001244671B2 (en) * 2000-03-31 2005-01-27 Daiichi Pharmaceutical Co., Ltd. Quinolonecarboxylic acid derivative
EP1712554A1 (en) 2004-02-02 2006-10-18 Daiichi Pharmaceutical Co., Ltd. Pyridobenzoxazine derivative
EP1757598A4 (en) 2004-05-13 2010-07-21 Daiichi Seiyaku Co SUBSTITUTED PYRROLIDINE DERIVATIVE
US7563805B2 (en) 2005-05-19 2009-07-21 Daiichi Pharmaceutical Co., Ltd. Tri-, tetra-substituted-3-aminopyrrolidine derivative

Also Published As

Publication number Publication date
AR054272A1 (es) 2007-06-13
JP2012193195A (ja) 2012-10-11
WO2006123792A1 (ja) 2006-11-23
EP1882689A4 (en) 2010-01-06
EP1882689B1 (en) 2013-07-10
US7563805B2 (en) 2009-07-21
IL186815A0 (en) 2008-02-09
CA2608468C (en) 2013-02-26
US20090253726A1 (en) 2009-10-08
NZ562959A (en) 2010-07-30
US20120232288A1 (en) 2012-09-13
IL186815A (en) 2013-09-30
KR101307717B1 (ko) 2013-09-11
US20060264428A1 (en) 2006-11-23
AU2006248354A1 (en) 2006-11-23
US8476429B2 (en) 2013-07-02
HK1116774A1 (en) 2009-01-02
TWI384987B (zh) 2013-02-11
US8211910B2 (en) 2012-07-03
BRPI0610114A2 (pt) 2010-06-01
ES2422858T3 (es) 2013-09-16
CA2608468A1 (en) 2006-11-23
JPWO2006123792A1 (ja) 2008-12-25
EP1882689A1 (en) 2008-01-30
TW200716131A (en) 2007-05-01
JP5475841B2 (ja) 2014-04-16
EP2463274A1 (en) 2012-06-13
MY143605A (en) 2011-06-15
KR20080020603A (ko) 2008-03-05
AU2006248354B2 (en) 2011-11-03
JP5087394B2 (ja) 2012-12-05

Similar Documents

Publication Publication Date Title
IL186815A (en) A 3-amino-3-alkyl-4-quinolone compound mono or 3-amino-3-alkyl-4, 4-substituted by pyrrolidinyl
NO20075312L (no) N-(N-sulfonylaminometyl)cyklopropankarboksamidderivater nyttige ved smertebehandling
NO20054425L (no) Heteroarylkarbamoylbenzenderivater
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
CY1117392T1 (el) Ενδιαμεσες ενωσεις για την παρασκευη μακροκυκλικων αναστολεων του ιου της ηπατιτιδας c
MY172034A (en) Intermediate for producing bicyclic ?-amino acid derivative
WO2007079186A3 (en) 1, 3-oxazolidin-2-one derivatives useful as cetp inhibitors
MY146646A (en) 2,3-dihydro-6-nitroimidazo [2,1-b] oxazole compounds for the treatment of tuberculosis
MX2009013728A (es) Derivados de bicicloanilina.
TW200510381A (en) Novel 2-pyridinecarboxamide derivatives
TW200745034A (en) New compounds
TR200401413T1 (tr) Dibenzilamin bileşikleri ve bunların farmasötik kullanımları
NO20052469L (no) Inhibitorer av II-beta-hydroksysteroid-dehydrogenase type 1 og type 2.
IN2012DN00999A (no)
MX2009005219A (es) Inhibidores macrociclicos del virus de hepatitis c.
EA017861B9 (ru) Способ получения 4-оксохинолинового соединения
MY169179A (en) Novel piperidine compound or salt thereof
CY1117923T1 (el) Αζωτουχος ετεροκυκλικη ενωση και γεωργικο ή κηπουρικο μυκητοκτονο
WO2009010765A3 (en) Lantibiotic-based compounds having antimicrobial activity
NO20062617L (no) Anvendelse av glukosidase inhibitorer for terapi av mucovisidose
NO20055632L (no) Aromatiske oksyfenyl- og aromatiske sulfanylfenylderivater
TW200720399A (en) Light-emitting element and iridium complex
NO20073787L (no) Nye pyrimidin-nukleosidforbindelser eller dets salt
NO20054135L (no) Kipolinon/benzoksazin derivater og anvendelser derav
DK0477903T3 (da) Substituerede 4-amino-3-pyridinoler, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application